BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 12825939)

  • 1. Histamine-releasing activity and binding to the FcepsilonRI alpha human mast cell receptor subunit of mast cell degranulating peptide analogues with alanine substitutions.
    Buku A; Mendlowitz M; Condie BA; Price JA
    J Med Chem; 2003 Jul; 46(14):3008-12. PubMed ID: 12825939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial alanine scan of mast cell degranulating peptide (MCD): importance of the histidine- and arginine residues.
    Buku A; Mendlowitz M; Condie BA; Price JA
    J Pept Sci; 2004 Jun; 10(6):313-7. PubMed ID: 15214434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ala12]MCD peptide: a lead peptide to inhibitors of immunoglobulin E binding to mast cell receptors.
    Buku A; Condie BA; Price JA; Mezei M
    J Pept Res; 2005 Sep; 66(3):132-7. PubMed ID: 16083440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective mast cell degranulating peptide inhibitors of the IgE/Fc epsilonRI receptor interaction.
    Buku A; Keselman I; Lupyan D; Mezei M; Price JA
    Chem Biol Drug Des; 2008 Aug; 72(2):133-9. PubMed ID: 18624811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional evidence for an intramolecular side chain interaction between residues 6 and 10 of receptor-bound parathyroid hormone analogues.
    Shimizu N; Petroni BD; Khatri A; Gardella TJ
    Biochemistry; 2003 Mar; 42(8):2282-90. PubMed ID: 12600195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action.
    Befus AD; Mowat C; Gilchrist M; Hu J; Solomon S; Bateman A
    J Immunol; 1999 Jul; 163(2):947-53. PubMed ID: 10395691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new FcεRI receptor-mimetic peptide (PepE) that blocks IgE binding to its high affinity receptor and prevents mediator release from RBL 2H3 cells.
    Sandomenico A; Monti SM; Palumbo R; Ruvo M
    J Pept Sci; 2011 Sep; 17(9):604-9. PubMed ID: 21538708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.
    Vig BS; Zheng MQ; Murray TF; Aldrich JV
    J Med Chem; 2003 Sep; 46(19):4002-8. PubMed ID: 12954053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [General principles of mast cell activation by cyclic analogs of basic vasoactive peptides].
    Porunkevich EA; Ratkevich MP; Kublis GG; Mutulis FK; Chipens GI
    Biokhimiia; 1990 Jun; 55(6):988-94. PubMed ID: 1698465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studies.
    Cervini LA; Donaldson CJ; Koerber SC; Vale WW; Rivier JE
    J Med Chem; 1998 Feb; 41(5):717-27. PubMed ID: 9513600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of ethanol's membrane actions and inhibition of receptor-stimulated histamine release from rat mast cells.
    Gonzales RA; Crews FT
    J Pharmacol Exp Ther; 1986 Oct; 239(1):111-6. PubMed ID: 2428970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgE receptors, IgE content and secretory response of mast cells in athymic rats.
    Chen XJ; Enerbäck L
    Immunology; 1994 Dec; 83(4):595-600. PubMed ID: 7533134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver fluke (Fasciola hepatica)-derived peptides activate rat peritoneal mast cells.
    Trudgett A; Watt AP; Harriott P; Ennis M
    Int Immunopharmacol; 2003 May; 3(5):775-81. PubMed ID: 12757746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further studies on the structural requirements for mast cell degranulating (MCD) peptide-mediated histamine release.
    Buku A; Price JA
    Peptides; 2001 Dec; 22(12):1987-91. PubMed ID: 11786181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
    Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adriamycin induces exocytosis in rat and beige mouse peritoneal mast cells: an ultrastructural, morphometric and biochemical study.
    Crivellato E; Candussio L; Decorti G; Klugmann FB; Mallardi F
    J Submicrosc Cytol Pathol; 1999 Apr; 31(2):279-86. PubMed ID: 10457614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cell degranulating peptide binds to RBL-2H3 mast cell receptors and inhibits IgE binding.
    Buku A; Price JA; Mendlowitz M; Masur S
    Peptides; 2001 Dec; 22(12):1993-8. PubMed ID: 11786182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid inhibitory effect of corticosterone on histamine release from rat peritoneal mast cells.
    Liu C; Zhou J; Zhang LD; Wang YX; Kang ZM; Chen YZ; Jiang CL
    Horm Metab Res; 2007 Apr; 39(4):273-7. PubMed ID: 17447165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors.
    Wang XS; Lau HY
    Allergy; 2006 Apr; 61(4):503-6. PubMed ID: 16512814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Potassium channel openers antagonize 4-aminopyridine induced histamine release from rat peritoneal mast cells].
    Chen ZG; Xu JH
    Yao Xue Xue Bao; 1995; 30(10):736-40. PubMed ID: 8701728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.